| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Business Development Off
1 company
Gano Kyle is a Chief Executive Officer at NEUROCRINE BIOSCIENCES INC. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $22.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 12, 2017 | NBIX Neurocrine Biosciences Inc | Chief Business Development Off | Sell | 13,065 | $50.42 | $658,773.93 | -8.2% | |
| Feb 6, 2017 | NBIX Neurocrine Biosciences Inc | Chief Business Development Off | Sell | 727 | $43.15 | $31,370.05 | -1.2% | |
| Feb 3, 2017 | NBIX Neurocrine Biosciences Inc | Chief Business Development Off | Sell | 1,375 | $42.57 | $58,533.75 | -2.2% | |
| Jan 17, 2017 | NBIX Neurocrine Biosciences Inc | Chief Business Development Off | Sell | 1,625 | $40.65 | $66,056.25 | -2.7% |